A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families

被引:0
|
作者
Serova, O
Montagna, M
Torchard, D
Narod, SA
Tonin, P
Sylla, B
Lynch, HT
Feunteun, J
Lenoir, GM
机构
[1] INT AGCY RES CANC,F-69372 LYON,FRANCE
[2] INST GUSTAVE ROUSSY,VILLEJUIF,FRANCE
[3] MCGILL UNIV,DEPT MED,DIV MED GENET,MONTREAL,PQ,CANADA
[4] MCGILL UNIV,DEPT HUMAN GENET,MONTREAL,PQ,CANADA
[5] CREIGHTON UNIV,SCH MED,DEPT PREVENT MED & PUBL HLTH,OMAHA,NE
关键词
D O I
暂无
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
We have analyzed 20 breast-ovarian cancer families, the majority of which show positive evidence of linkage to chromosome 17q12, for germ-line mutations in the BRCA1 gene. BRCA1 mutations cosegregating with breast and ovarian cancer susceptibility were identified in 16 families, including 1 family with a case of male breast cancer. Nine of these mutations have not been reported previously. The majority of mutations were found to generate a premature stop codon leading to the formation of a truncated BRCA1 protein of 2%-88% of the expected normal length. Two mutations altered the RING finger domain. Sequencing of genomic DNA led to the identification of a mutation in the coding region of BRCA1 in 12 families, and cDNA analysis revealed an abnormal or missing BRCA1 transcript in 4 of the 8 remaining families. A total of eight mutations were associated with a reduced quantity of BRCA1 transcript. We were unable to detect BRCA1 mutations in 4 of the 20 families, but only 1 of these was clearly linked to BRCA1. Ir is expected that the majority of clear examples of the breast-ovarian cancer syndrome will be associated with germ-line mutations in the coding region of BRCA1.
引用
收藏
页码:42 / 51
页数:10
相关论文
共 50 条
  • [21] Large BRCA1 and BRCA2 genomic rearrangements in Danish high risk breast-ovarian cancer families
    Hansen, Thomas Van O.
    Jonson, Lars
    Albrechtsen, Anders
    Andersen, Mette K.
    Ejlertsen, Bent
    Nielsen, Finn C.
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 115 (02) : 315 - 323
  • [22] Familial breast-ovarian cancer syndromes: BRCA1 and BRCA2
    Berchuck, A
    Carney, M
    Lancaster, JM
    Marks, J
    Futreal, AP
    CLINICAL OBSTETRICS AND GYNECOLOGY, 1998, 41 (01): : 157 - 166
  • [23] BRCA1 and BRCA2 Mutation Analysis in Breast-Ovarian Cancer Families From Northeastern Poland
    Perkowska, Magdalena
    Brozek, Izabela
    Wysocka, Barbara
    Haraldsson, Karin
    Sandberg, Therese
    Johansson, Ulla
    Sellberg, Gunilla
    Borg, Ake
    Limon, Janusz
    HUMAN MUTATION, 2003, 21 (05)
  • [24] Incidence of non-founder BRCA1 and BRCA2 mutations in high risk Ashkenazi breast and ovarian cancer families
    Kauff, ND
    Perez-Segura, P
    Robson, ME
    Scheuer, L
    Siegel, B
    Schluger, A
    Rapaport, B
    Frank, TS
    Nafa, K
    Ellis, NA
    Parmigiani, G
    Offit, K
    JOURNAL OF MEDICAL GENETICS, 2002, 39 (08) : 611 - 614
  • [25] Comparative analysis of methods for detecting BRCA1 rearrangements in breast-ovarian cancer families.
    Bressac-de Paillerets, B
    Di Rocco, ZC
    Gad, S
    Bièche, I
    Coulet, F
    Barrois, M
    Casilli, F
    Mazoyer, S
    Chompret, A
    Maugard, CM
    Olschwang, S
    Frebourg, T
    Soubrier, F
    Lidereau, R
    Stoppa-Lyonnet, D
    Tosi, M
    AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) : 248 - 248
  • [26] Novel BRCA1/2 mutations in Serbian breast and breast-ovarian cancer patients with hereditary predisposition
    Dobricic, Jelena
    Brankovic-Magic, Mirjana
    Filipovic, Sladana
    Radulovic, Sinisa
    CANCER GENETICS AND CYTOGENETICS, 2010, 202 (01) : 27 - 32
  • [27] GENETIC SCREENING FOR BRCA1 MUTATIONS IN BREAST AND/OR OVARIAN-CANCER FAMILIES
    TARTAGLINI, E
    BADZIOCH, M
    ANDERSON, D
    SAUNDERS, GF
    AMERICAN JOURNAL OF HUMAN GENETICS, 1995, 57 (04) : 419 - 419
  • [28] High prevalence of BRCA1 founder mutations in Greek breast/ovarian families
    Konstantopoulou, I.
    Tsitlaidou, M.
    Fostira, F.
    Pertesi, M.
    Stavropoulou, A-V
    Triantafyllidou, O.
    Tsotra, E.
    Tsiftsoglou, A. P.
    Tsionou, C.
    Droufakou, S.
    Dimitrakakis, C.
    Fountzilas, G.
    Yannoukakos, D.
    CLINICAL GENETICS, 2014, 85 (01) : 36 - 42
  • [29] BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and ovarian cancer
    Schubert, EL
    Mefford, HC
    Dann, JL
    Argonza, RH
    Hull, J
    King, MC
    GENETIC TESTING, 1997, 1 (01): : 41 - 46
  • [30] BRCA1 and BRCA2 mutations in Danish families with hereditary breast and/or ovarian cancer
    Thomassen, Mads
    Hansen, Thomas V. O.
    Borg, Ake
    Lianee, Henriette Theilmann
    Wikman, Friedrik
    Pedersen, Inge Sokilde
    Bisgaard, Marie Luise
    Nielsen, Finn C.
    Kruse, Torben A.
    Gerdes, Anne-Marie
    ACTA ONCOLOGICA, 2008, 47 (04) : 772 - 777